Volume 856, Issue 1

PharmacoEconomics & Outcomes News is now archived and no longer receiving submissions with this publisher. All articles published in the journal during its time with Springer will remain fully searchable through our websites.

Search all PharmacoEconomics & Outcomes News articles

June 2020

June 27, 2020

37 articles in this issue

Generic substitution by pharmacists could be cost saving in US

News item 27 June 2020 Pages: 1 - 1
ICER assessing inclisiran and bempedoic acid for high cholesterol

News item 27 June 2020 Pages: 2 - 2
ICER review on unsupported drug price increases in USA

News item 27 June 2020 Pages: 3 - 3
Amoxicillin low-value care in chronic low back pain

Clinical study 27 June 2020 Pages: 4 - 4
Atezolizumab not cost effective in advanced NSCLC

Clinical study 27 June 2020 Pages: 5 - 5
Brain injury score plus CT cost effective in detecting head trauma

Clinical study 27 June 2020 Pages: 6 - 6
Budget impact analysis of hydrophobic versus hydrophilic lenses

Clinical study 27 June 2020 Pages: 7 - 7
Clinical medication review in elderly with polypharmacy saves cost

Clinical study 27 June 2020 Pages: 8 - 8
Computerised tool reduces polypharmacy but not AEs in elderly

Clinical study 27 June 2020 Pages: 9 - 9
Cost effectiveness of 9-valent HPV vaccine for cervical cancer prevention

Review 27 June 2020 Pages: 10 - 10
Costs of evaluating β-lactamase inhibitor allergy in children

Clinical study 27 June 2020 Pages: 11 - 11
Disparities between lost earnings due to death from cancer in USA

Clinical study 27 June 2020 Pages: 12 - 12
Do US Medicare accountable care organisations improve care, cut cost?

Clinical study 27 June 2020 Pages: 13 - 13
Drug costs for metastatic NSCLC stable, overall survival benefit poor

Clinical study 27 June 2020 Pages: 14 - 14
Financial conflicts of interest "very common" among US cancer guidelines panellists

Clinical study 27 June 2020 Pages: 15 - 15
First-line ibrutinib in untreated CLL: QOL improvement at high cost

Clinical study 27 June 2020 Pages: 16 - 16
Gaps in funding of high cost drugs for rare diseases in England

Clinical study 27 June 2020 Pages: 17 - 17
Is BRCA1/2 testing for women at high cancer risk cost effective in Brazil?

Clinical study 27 June 2020 Pages: 18 - 18
Merit in retaining ICER alongside net benefit

Comment 27 June 2020 Pages: 19 - 19
Multiple orphan drugs have extended exclusivity periods in the US

Non-clinical study 27 June 2020 Pages: 20 - 20
OOP burden for COVID-19-like respiratory hospitalisations varies in US

Clinical study 27 June 2020 Pages: 21 - 21
OOP costs high in older Australians with hypertension

Clinical study 27 June 2020 Pages: 22 - 22
Optimum varicella vaccine recommendation for Italy

Clinical study 27 June 2020 Pages: 23 - 23
Pneumococcal vaccine not cost effective at 65 years in Sweden

Clinical study 27 June 2020 Pages: 24 - 24
Point-of-care assays good value for infant HIV diagnosis in Zimbabwe

Clinical study 27 June 2020 Pages: 25 - 25
Potential cost savings with internet intervention for depression

Epidemiology clinical study 27 June 2020 Pages: 26 - 26
Quadrivalent influenza vaccine cost effective in South Korea

Clinical study 27 June 2020 Pages: 27 - 27
Quantifying the cost burden of hepatitis C

Clinical study 27 June 2020 Pages: 28 - 28
Ravulizumab cost effective for paroxysmal nocturnal haemoglobinuria

Clinical study 27 June 2020 Pages: 29 - 29
Reimbursement of telehealth appointments for paediatric allergies

Clinical study 27 June 2020 Pages: 30 - 30
Results of perinatal hepB prevention programme in Sth Korea "promising"

Clinical study 27 June 2020 Pages: 31 - 31
Rifampin more affordable than isoniazid for latent tuberculosis infection

Clinical study 27 June 2020 Pages: 32 - 32
Rivaroxaban plus aspirin cost effective as antithrombotic treatment in Finland

Clinical study 27 June 2020 Pages: 33 - 33
Routine rotavirus vaccination not cost effective in Bhutan

Clinical study 27 June 2020 Pages: 34 - 34
Savings with insulin glargine biosimilars in England could be much higher

Clinical study 27 June 2020 Pages: 35 - 35
Small savings generated with bundled payments in the US

Clinical study 27 June 2020 Pages: 36 - 36
Spinal muscular atrophy incurs high financial burden in Australia

Clinical study 27 June 2020 Pages: 37 - 37

Volume 856, Issue 1

Generic substitution by pharmacists could be cost saving in US

ICER assessing inclisiran and bempedoic acid for high cholesterol

ICER review on unsupported drug price increases in USA

Amoxicillin low-value care in chronic low back pain

Atezolizumab not cost effective in advanced NSCLC

Brain injury score plus CT cost effective in detecting head trauma

Budget impact analysis of hydrophobic versus hydrophilic lenses

Clinical medication review in elderly with polypharmacy saves cost

Computerised tool reduces polypharmacy but not AEs in elderly

Cost effectiveness of 9-valent HPV vaccine for cervical cancer prevention

Costs of evaluating β-lactamase inhibitor allergy in children

Disparities between lost earnings due to death from cancer in USA

Do US Medicare accountable care organisations improve care, cut cost?

Drug costs for metastatic NSCLC stable, overall survival benefit poor

Financial conflicts of interest "very common" among US cancer guidelines panellists

First-line ibrutinib in untreated CLL: QOL improvement at high cost

Gaps in funding of high cost drugs for rare diseases in England

Is BRCA1/2 testing for women at high cancer risk cost effective in Brazil?

Merit in retaining ICER alongside net benefit

Multiple orphan drugs have extended exclusivity periods in the US

OOP burden for COVID-19-like respiratory hospitalisations varies in US

OOP costs high in older Australians with hypertension

Optimum varicella vaccine recommendation for Italy

Pneumococcal vaccine not cost effective at 65 years in Sweden

Point-of-care assays good value for infant HIV diagnosis in Zimbabwe

Potential cost savings with internet intervention for depression

Quadrivalent influenza vaccine cost effective in South Korea

Quantifying the cost burden of hepatitis C

Ravulizumab cost effective for paroxysmal nocturnal haemoglobinuria

Reimbursement of telehealth appointments for paediatric allergies

Results of perinatal hepB prevention programme in Sth Korea "promising"

Rifampin more affordable than isoniazid for latent tuberculosis infection

Rivaroxaban plus aspirin cost effective as antithrombotic treatment in Finland

Routine rotavirus vaccination not cost effective in Bhutan

Savings with insulin glargine biosimilars in England could be much higher

Small savings generated with bundled payments in the US

Spinal muscular atrophy incurs high financial burden in Australia

Navigation